Vicore Pharma Holding AB: Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn
GOTHENBURG, Sweden, Aug. 19, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore"), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2